GotoBiopharm Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
893
- Stock Symbol
-
300966
- Investments
-
1
- Share Price
-
$3.03
- (As of Friday Closing)
GotoBiopharm General Information
Description
Hubei Goto Biopharm Group Co Ltd is engaged in the research, development, production and sales of steroidal drug raw materials. The company's main products are starting materials, intermediates and active pharmaceutical ingredients required for the production of steroid drugs.
Contact Information
Corporate Office
- 5th Floor, East Gate of Building #2, Servo-industrial Park
- 1st Qilin Road
- Xiangyang, Hubei 441000
- China
Corporate Office
- 5th Floor, East Gate of Building #2, Servo-industrial Park
- 1st Qilin Road
- Xiangyang, Hubei 441000
- China
GotoBiopharm Stock Performance
As of 20-Nov-2026, GotoBiopharm’s stock price is $3.03. Its current market cap is $349M with 115M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.03 | $3.27 | $2.68 - $4.80 | $349M | 115M | 2.28M | -$0.11 |
GotoBiopharm Financials Summary
As of 30-Sep-2026, GotoBiopharm has a trailing 12-month revenue of $96.6M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 639,441 | 504,597 | 388,804 | 467,100 |
| Revenue | 96,582 | 84,293 | 74,782 | 80,058 |
| EBITDA | (9,018) | 7,945 | 2,812 | 8,251 |
| Net Income | (13,013) | (10,201) | (3,845) | 3,252 |
| Total Assets | 440,788 | 407,429 | 382,170 | 345,307 |
| Total Debt | 203,165 | 185,695 | 155,005 | 110,844 |
GotoBiopharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GotoBiopharm Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
GotoBiopharm Signals
GotoBiopharm Investments (1)
GotoBiopharm’s most recent deal was a Joint Venture with Huahai Gongtong.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Huahai Gongtong | Joint Venture | Pharmaceuticals |
GotoBiopharm ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
GotoBiopharm FAQs
-
When was GotoBiopharm founded?
GotoBiopharm was founded in 2006.
-
Where is GotoBiopharm headquartered?
GotoBiopharm is headquartered in Xiangyang, China.
-
What is the size of GotoBiopharm?
GotoBiopharm has 893 total employees.
-
What industry is GotoBiopharm in?
GotoBiopharm’s primary industry is Pharmaceuticals.
-
Is GotoBiopharm a private or public company?
GotoBiopharm is a Public company.
-
What is GotoBiopharm’s stock symbol?
The ticker symbol for GotoBiopharm is 300966.
-
What is the current stock price of GotoBiopharm?
As of 20-Nov-2026 the stock price of GotoBiopharm is $3.03.
-
What is the current market cap of GotoBiopharm?
The current market capitalization of GotoBiopharm is $349M.
-
What is GotoBiopharm’s current revenue?
The trailing twelve month revenue for GotoBiopharm is $96.6M.
-
What is GotoBiopharm’s annual earnings per share (EPS)?
GotoBiopharm’s EPS for 12 months was -$0.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process